The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
OBX-115 engineered tumor-infiltrating lymphocyte (TIL) cell therapy with regulatable membrane-bound IL15 (mbIL15) in patients (pts) with immune checkpoint inhibitor (ICI)–resistant advanced melanoma: Phase 1 results of the Agni-01 multicenter study.
 
Jason Chesney
Consulting or Advisory Role - Iovance Biotherapeutics; Iovance Biotherapeutics
Research Funding - Amgen; Bristol-Myers Squibb; Iovance Biotherapeutics; Replimune
Patents, Royalties, Other Intellectual Property - University of Louisville US Patents
 
Gino In
Honoraria - Array BioPharma/Pfizer; Bristol-Myers Squibb; Pfizer; regeneron; Sanofi
Consulting or Advisory Role - Bristol-Myers Squibb; Castle Biosciences; Novartis; Pfizer; Replimune; Sanofi
Speakers' Bureau - Merck; Regeneron; Rockpointe CME; Targeted Oncology
Research Funding - Bicara Therapeutics (Inst); Checkmate Pharmaceuticals (Inst); Georgiamune (Inst); Idera (Inst); Immunocore (Inst); Instil Bio (Inst); Iovance Biotherapeutics (Inst); Merck (Inst); Obsidian Therapeutics (Inst); Pfizer (Inst); Regeneron (Inst); Replimune (Inst); Xencor (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb/Pfizer; Pfizer; Regeneron
 
Alexander Shoushtari
Consulting or Advisory Role - Erasca, Inc; Immunocore
Research Funding - Bristol-Myers Squibb (Inst); IDEAYA Biosciences (Inst); Immunocore (Inst); Iovance Biotherapeutics (Inst); Linnaeus Therapeutics (Inst); Merck (Inst); Mural Oncology (Inst); Novartis (Inst); Obsidian Therapeutics (Inst); Pfizer (Inst)
Patents, Royalties, Other Intellectual Property - UpToDate
 
Justin Moyers
Consulting or Advisory Role - OncLive/MJH Life Sciences; Pfizer; Replimune
Speakers' Bureau - Clinical Care Options; Curio Science
 
Yazan Samhouri
Consulting or Advisory Role - Abbvie; ADC Therapeutics; BeiGene; Epizyme; Genentech
 
Tirrell Johnson
No Relationships to Disclose
 
Rodabe Amaria
Consulting or Advisory Role - Erasca, Inc; IO Biotech; KSQ Therapeutics; Obsidian Therapeutics; Replimune
Research Funding - Bristol-Myers Squibb (Inst); Erasc (Inst); Genentech (Inst); iovance Biotherapeutics (Inst); KSQ Therapeutics (Inst); Novartis (Inst); Obsidian Therapeutics (Inst); OnKure (Inst); Regeneron (Inst)
 
Giridharan Ramsingh
Employment - Obsidian Therapeutics
Stock and Other Ownership Interests - Obsidian Therapeutics
Travel, Accommodations, Expenses - Obsidian Therapeutics
 
Camille Renard
Employment - Obsidian Therapeutics
Stock and Other Ownership Interests - Obsidian Therapeutics
Travel, Accommodations, Expenses - Obsidian Therapeutics
 
Raina Duan
Employment - Obsidian Therapeutics
Stock and Other Ownership Interests - Obsidian Therapeutics
Travel, Accommodations, Expenses - Obsidian Therapeutics
 
Lauren McLaughlin
Employment - Obsidian Therapeutics
Stock and Other Ownership Interests - Obsidian Therapeutics
Travel, Accommodations, Expenses - Obsidian Therapeutics
 
Allison Betof Warner
Consulting or Advisory Role - Adaptimmune; BluePath Solutions; Bristol-Myers Squibb/Medarex; immatics; IO Biotech; Iovance Biotherapeutics; Merck; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb/Medarex (Inst); Iovance Biotherapeutics (Inst); Lyell Immunopharma (Inst); Obsid (Inst)